Winton Capital »

Avadel Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $727k 48k 15.27

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ge Vernova (GEV)
Select Sector Spdr Tr Sbi Materials (XLB)
Devon Energy Corporation (DVN)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Fastenal Company (FAST)
Incyte Corporation (INCY)
Masco Corporation (MAS)
Five Below (FIVE)
Johnson Ctls Intl SHS (JCI)

View all positions for Winton Capital

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Vanguard Group
Brandes Investment Partners
Two Seas Capital
Jeffrey L. Gendell
Polar Capital Holdings
Vivo Capital
State Street Corporation
Wealth Effects
Geode Capital Management
Tang Capital Management
Susquehanna International
Kennedy Capital Management
Citadel Advisors

View all funds holding Avadel Pharmaceuticals